Cervical cancer screening has been the 20th century poster child for preventative screening. This presentation is a gynecologist’s perspective on its continuing evolution –both as a great success and an opportunity for improvement. Dr Baker will focus on the transition from experience based to data driven development of guidelines for physicians. He will also reflect on the challenges for molecular laboratories. Their anticipation of changes in screening practice and potential impact to their range of services including consultative role to OB/Gyn physicians.
1) The attendee will understand how and why the approach to cervical cancer screening is evolving.
2) The attendee will understand how these changes might impact the molecular lab and it's relationship with OB/GYNs.